Publications by authors named "Alexander Lyon"

Claim this Profile
F
Forward and reverse cardio-oncology.
Wouter C Meijers, Joseph Pierre Aboumsallem, Alexander R Lyon, Javid Moslehi, Rudolf A de Boer

Physiol Rev· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of a cardio-oncology clinical nurse specialist in the United Kingdom.
Priya Reehal, Alexander R Lyon, Geraldine Lee

Asia Pac J Oncol Nurs· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
ESC cardio-oncology conference hits the ground running.
Pietro Ameri, Alexander R Lyon, Teresa López Fernández

Eur Heart J· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune Checkpoint Inhibitor-Associated Cardiovascular Toxic Effects: International Cardio-Oncology Society Position Statement.
Joerg Herrmann, Ana Barac, Joseph Carver, Richard K Cheng, Andres Daniele, Alexander R Lyon

JAMA Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy and the heart: Understanding the cardiovascular risks of immune checkpoint inhibitors.
Maria Sol Andres, Maria Clara Llamedo, Sivatharshini Ramalingam, Alexander R Lyon

Presse Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-bacterial thrombotic endocarditis in cancer.
Francois Deharo, Alexander R Lyon, Franck Thuny

Eur Heart J· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imaging Immune Checkpoint Inhibitor Myocarditis: Can We Do Better?
Edward Doris, Charlotte Manisty, Sivatharshini Ramalingam, Gary J R Cook, Alexander R Lyon

JACC CardioOncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heart failure with preserved ejection fraction in cancer patients and survivors. A scientific statement of the Heart Failure Association of the ESC and the ESC Council of Cardio-Oncology.
Kalliopi Keramida, Teresa Lopez-Fernandez, Markus S Anker, Mark C Petrie, Pietro Ameri, Alexander R Lyon

Eur J Heart Fail· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How to facilitate seamless translation from basic concepts to new heart failure drugs. A scientific statement of the Heart Failure Association of the ESC.
Carlo Gabriele Tocchetti, Arantxa González, Johannes Backs, Piero Pollesello, Peter P Rainer, Alexander R Lyon

Eur J Heart Fail· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune checkpoint inhibitor myocarditis-a score to tell you more.
Joerg Herrmann, Alexander R Lyon

Eur Heart J· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of sodium-glucose cotransporter 2 inhibitors in patients with cancer and diabetes mellitus: a systematic review and meta-analysis.
Giuseppina Novo, Cristina Madaudo, Antonio Cannatà, Pietro Ameri, Daniela Di Lisi, Alexander R Lyon

Eur Heart J Cardiovasc Pharmacother· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevention of cancer therapy-related cardiac dysfunction and heart failure in cancer patients and survivors. A Clinical Consensus Statement of the Heart Failure Association, the European Association of Preventive Cardiology of the ESC, and the ESC Council of Cardio-Oncology.
Amina Rakisheva, Dimitrios Farmakis, Andrea Attanasio, Antoni Bayes Genis, Alain Cohen-Solal, Alexander R Lyon

Eur J Heart Fail· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Update on preclinical models of cancer therapy-related cardiac dysfunction: Challenges and perspectives. A scientific statement of the Heart Failure Association (HFA) of the ESC, the ESC Council of Cardio-Oncology, and the ESC Working Group on Cellular Biology of the Heart.
Alessandra Ghigo, Pietro Ameri, Aarti Asnani, Edoardo Bertero, Rudolf A de Boer, Alexander R Lyon

Eur J Heart Fail· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardioprotective drugs and heart failure/cardiomyopathy incidence in chemotherapy-treated cancer survivors of breast cancer and non-Hodgkin lymphoma: a retrospective cohort study in England.
Pooja Hindocha, Alexander R Lyon, Krishnan Bhaskaran, Helen Strongman

Eur Heart J Open· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The year in cardiovascular medicine 2024: the top 10 papers in cardio-oncology.
Joerg Herrmann, Teresa López-Fernández, Alexander R Lyon

Eur Heart J· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An update on the European Society of Cardiology Council of Cardio-Oncology.
Teresa López-Fernández, Peter van der Meer, Alexander R Lyon

Eur Heart J· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality-of-Care Measures for Cardio-Oncology: An IC-OS and ACC Cardio-Oncology Leadership Council Perspective.
Vijay U Rao, Anita Deswal, Daniel Lenihan, Susan Dent, Teresa Lopez-Fernandez, Alexander R Lyon

JACC CardioOncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mobile/wearable digital devices for care of active cancer patients: a survey from the ESC Council of Cardio-Oncology.
Giuseppe Boriani, Jacopo F Imberti, Riccardo Asteggiano, Pietro Ameri, Davide A Mei, Alexander R Lyon

Eur Heart J Digit Health· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HER-SAFE study design: an open-label, randomised controlled trial to investigate the safety of withdrawal of pharmacological treatment for recovered HER2-targeted therapy-related cardiac dysfunction.
Benjamin Dowsing, Hakim-Moulay Dehbi, Robin Chung, Joanna Pedra, Orla Worn, Alexander R Lyon

BMJ Open· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perfect is the enemy of good: Reply to Struikmans et al.
Marianne C Aznar, Jutta Bergler-Klein, Giuseppe Boriani, David J Cutter, Coen Hurkmans, Alexander R Lyon

Radiother Oncol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk Assessment Prior to Cardiotoxic Anticancer Therapies in 7 Steps.
Jieli Tong, Isabelle Senechal, Sivatharshini Ramalingam, Alexander R Lyon

Br J Hosp Med (Lond)· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk Stratification, Screening and Treatment of BRAF/MEK Inhibitors-Associated Cardiotoxicity.
Isabelle Senechal, Maria Sol Andres, Jieli Tong, Sivatharshini Ramalingam, Muhummad Sohaib Nazir, Alexander R Lyon

Curr Oncol Rep· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Digital solutions to optimize guideline-directed medical therapy prescription rates in patients with heart failure: a clinical consensus statement from the ESC Working Group on e-Cardiology, the Heart Failure Association of the European Society of Cardiology, the Association of Cardiovascular Nursing & Allied Professions of the European Society of Cardiology, the ESC Digital Health Committee, the ESC Council of Cardio-Oncology, and the ESC Patient Forum.
Mark Johan Schuuring, Roderick Willem Treskes, Teresa Castiello, Magnus Thorsten Jensen, Ruben Casado-Arroyo, Alexander R Lyon

Eur Heart J Digit Health· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The right heart in patients with cancer. A scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Council of Cardio-Oncology.
Kalliopi Keramida, Dimitrios Farmakis, Amina Rakisheva, Carlo Gabriele Tocchetti, Pietro Ameri, Alexander R Lyon

Eur J Heart Fail· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complementary use of cardiac magnetic resonance and 18 F-FDG positron emission tomography imaging in suspected immune checkpoint inhibitor myocarditis.
Jieli Tong, Nikolaos Vogiatzakis, Maria Sol Andres, Isabelle Senechal, Ahmed Badr, Alexander R Lyon

Cardiooncology· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis